We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

76 hedge funds and large institutions have $8.75M invested in Ampio Pharmaceuticals Inc. in 2019 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 12 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

557% more call options, than puts

Call options by funds: $138K | Put options by funds: $21K

39% more capital invested

Capital invested by funds: $6.3M → $8.75M (+$2.45M)

17% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 12

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 75 → 76 (+1)

Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
14
Reduced
12
Closed
10
Calls
$138K
Puts
$21K
Net Calls
+$117K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$345K
2
CH
CVI Holdings
Delaware
+$240K
3
VFA
Valeo Financial Advisors
Indiana
+$235K
4
HIS
Harvest Investment Services
Illinois
+$47.1K
5
BJL
Brighton Jones LLC
Washington
+$23.9K

Top Sellers

Rank Fund Capital Flow
1
WWM
Western Wealth Management
Colorado
-$263K
2
Millennium Management
Millennium Management
New York
-$36.8K
3
Deutsche Bank
Deutsche Bank
Germany
-$22.2K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$21K
5
CCMW
Cypress Capital Management (Wyoming)
Wyoming
-$18.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$37K -$36.8K -285 -57%
RJFSA
27
Raymond James Financial Services Advisors
Florida
$32K – – –
SGCA
28
Steel Grove Capital Advisors
Tennessee
$32K – – –
TFS
29
TrustCore Financial Services
Tennessee
$32K +$7.23K +56 +44%
CPIG
30
Chicago Partners Investment Group
Illinois
$31K +$3.36K +26 +18%
HAG
31
HighPoint Advisor Group
Illinois
$29K – – –
Citadel Advisors
32
Citadel Advisors
Florida
$28K -$7.36K -57 -26%
UCFA
33
United Capital Financial Advisors
Texas
$28K +$517 +4 +3%
State Street
34
State Street
Massachusetts
$27K – – –
GWM
35
Geneos Wealth Management
Colorado
$22K – – –
UBS Group
36
UBS Group
Switzerland
$21K -$3.88K -30 -20%
JWA
37
JFS Wealth Advisors
Pennsylvania
$20K +$4.26K +33 +39%
WP
38
WealthPLAN Partners
Nebraska
$19K +$12.7K +98 New
MAM
39
Marotta Asset Management
Virginia
$16.8K +$10.3K +80 New
CCB
40
Cutter & Co Brokerage
Missouri
$15K – – –
Deutsche Bank
41
Deutsche Bank
Germany
$13K -$22.2K -172 -70%
Citigroup
42
Citigroup
New York
$13K – – –
TRCT
43
Tower Research Capital (TRC)
New York
$13K +$7.75K +60 +500%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$12K – – –
MMA
45
Miracle Mile Advisors
California
$12K +$8.65K +67 New
VF
46
Virtu Financial
New York
$10K -$5.68K -44 -44%
Morgan Stanley
47
Morgan Stanley
New York
$10K -$1.81K -14 -20%
Brown Advisory
48
Brown Advisory
Maryland
$10K – – –
JWM
49
Janiczek Wealth Management
Colorado
$10K – – –
Wells Fargo
50
Wells Fargo
California
$10K +$646 +5 +9%
1
2
3 4

AMPE Hedge Fund Activity: Q4 2019 in Review

76 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q4 2019, worth a combined $8.75M — up 39% from $6.3M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AMPE positions and 10 closed out — a net gain of 1 holder — while 14 added to existing stakes and 12 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $345K. The largest seller was Western Wealth Management, exiting entirely with an estimated $263K sold.

  • 76 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q4 2019, up from 75 in Q3 2019.
  • Funds reported $8.75M of Ampio Pharmaceuticals Inc. stock for Q4 2019, up 39% quarter-over-quarter.
  • 11 funds opened new Ampio Pharmaceuticals Inc. positions in Q4 2019 and 10 closed out, a net change of +1 holder.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q4 2019 was Susquehanna International Group, an estimated $345K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q4 2019 was Western Wealth Management, an estimated $263K sold.

Based on aggregated 13F filings for Q4 2019.